Open for feedback
Ngā Paerewa Health and Disability Services Standard Sector Guidance Review
HealthCERT is conducting the second two-yearly review of Ngā Paerewa Health and disability services standard (NZS 8134:2021) Sector Guidance to ensure it remains accurate, relevant, and supportive of sector needs: https://www.health.govt.nz/publications/sector-guidance-for-nga-paerewa-health-and-disability-services-standard-nzs-81342021 This review is an important opportunity to strengthen the guidance so it is practical, clear, and meets the...
Experiences with cervical screening
A Parliamentary Review Committee has been established to independently review the performance of the National Cervical Screening Programme and make recommendations to support its improvement. One focus of this review is the recent shift to HPV testing as the primary method for cervical screening (this is the vaginal swab that people can choose to do themselves). The other type of test you can do is a cervical cell sample (known as a smear test). If you have had any...
Closed for feedback
Proposed amendments to the designated pharmacist prescriber specified prescription medicines list
The Ministry of Health – Manatū Hauora (the Ministry) invites submissions on the proposed addition of 21 prescription medicines and one medicine class (vaccines) to the specified prescription...
Proposed amendments to the designated registered nurse prescriber specified prescription medicines list
The Ministry of Health – Manatū Hauora (the Ministry) invites submissions on the proposed addition of 190 prescription medicines and four medicine classes to the designated registered nurse...
Safe Areas - Survey
The Ministry of Health | Manatū Hauora (the Ministry) is conducting its annual survey to understand provider experiences and observations following the establishment of a Safe Area around their...
Clozapine: Proposed changes to blood monitoring and prescribing requirements - consultation questions for consumers and families
This Medsafe consultation seeks your feedback on proposed changes to the blood monitoring for clozapine. We are running this consultation on behalf of the companies that distribute...
Clozapine: Proposed changes to blood monitoring and prescribing requirements - consultation questions for healthcare professionals
This Medsafe consultation seeks your feedback on proposed changes to the blood monitoring and prescribing requirements for clozapine. We are running this consultation on behalf of the companies that...
Topical corticosteroids: Proposal for the package labelling to state their potency
Medsafe is seeking your feedback on a proposed advisory statement for topical corticosteroids to include information about the potency (strength) on the container/package label. In March...